ArticleScientific reports2020

The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study.

Letizia Porcelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.